Search Results - "Pasold, R"

Individual Patient Data–Based Meta-Analysis of Patients Aged 16 to 60 Years With Core Binding Factor Acute Myeloid Leukemia: A Survey of the German Acute Myeloid Leukemia Intergroup by SCHLENK, R. F, BENNER, A, PASOLD, R, DÖHNER, K, GANSER, A, DÖHNER, H, HEIL, G, KRAUTER, J, BÜCHNER, T, SAUERLAND, C, EHNINGER, G, SCHAICH, M, MOHR, B, NIEDERWIESER, D, KRAHL, R

“…To evaluate prognostic factors for relapse-free survival (RFS) and overall survival (OS) and to assess the impact of different postremission therapies in adult…”
Get full text

Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO) by Pönisch, W, Mitrou, P S, Merkle, K, Herold, M, Assmann, M, Wilhelm, G, Dachselt, K, Richter, P, Schirmer, V, Schulze, A, Subert, R, Harksel, B, Grobe, N, Stelzer, E, Schulze, M, Bittrich, A, Freund, M, Pasold, R, Friedrich, Th, Helbig, W, Niederwieser, D

“…This randomized phase III study compared bendamustine and prednisone (BP) to standard melphalan and prednisone (MP) treatment in previously untreated patients…”
Get full text

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-hodgkin's lymphoma and mantle cell lymphoma : results of a randomised phase III trial (OSHO# 19) by HEROLD, M, SCHUIZE, A, SCHIRMER, V, WENIGER, J, PASOLD, R, WINKELMANN, C, KLINKENSTEIN, C, SCHUIZE, M, ARZBERGER, H, BREMER, K, HAHNFELD, S, SCHWARZER, A, NIEDERWIESER, D, MÜLLER, C, MÜLLER, Chr, FRANKE, A, FRICKE, H. J, RICHTER, P, FREUND, M, ISMER, B, DACHSELT, K, BOEWER, C

“…The purpose of this study was to compare the efficacy and toxicity of bendamustine, vincristine + prednisone (BOP) with a standard regimen of cyclophosphamide,…”
Get full text

Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab by HEROLD, M, DÖLKEN, G, FIEDLER, F, FRANKE, A, FREUND, M, HELBIG, W, PASOLD, R

Get full text

Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia by Hofmann, W K, Seipelt, G, Langenhan, S, Reutzel, R, Schott, D, Schoeffski, O, Illiger, H J, Hartmann, F, Balleisen, L, Franke, A, Fiedler, F, Huber, C, Rasche, H, Bergmann, L, Ganser, A, Pott, C, Pasold, R, Rudolph, C, Ottmann, O G, Gökbuget, N, Hoelzer, D

“…In acute lymphoblastic leukemia (ALL), treatment with granulocyte colony stimulating factor (G-CSF) during remission induction shortens granulocytopenia and…”
Get full text

Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia by Eichhorst, Barbara F., Busch, Raymonde, Hopfinger, Georg, Pasold, Rita, Hensel, Manfred, Steinbrecher, Cordelia, Siehl, Siegfried, Jäger, Ulrich, Bergmann, Manuela, Stilgenbauer, Stephan, Schweighofer, Carmen, Wendtner, Clemens M., Döhner, Hartmut, Brittinger, Günter, Emmerich, Bertold, Hallek, Michael

“…Combination chemotherapy with fludarabine plus cyclophosphamide (FC) was compared with the standard regimen of fludarabine monotherapy in first-line treatment…”
Get full text

An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients by HÖFFKEN, G, PASOLD, R, PFLÜGER, K. H, FINKE, J, FAUSER, A. A, SZELENYI, H, WAGNER, J

“…To reduce drug acquisition costs, the clinical and bacteriological efficacy of low-dose ceftazidime iv (1 g tid) was compared with cefotaxime iv (2 g tid)…”
Get full text

Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML : impact of different mobilisation regimens by DEININGER, M, PÖNISCH, W, VON GRÜNHAGEN, U, HEROLD, M, DÖLKEN, G, HOFFMANN, F. A, UHLE, R, SCHULTZE, W, STEGLICH, J, SCHWARZER, A, RICHTER, P, WINKELMANN, C, KRAHL, R, KETTNER, E, DACHSELT, K, SUBERT, R, SCHWALBE, E, DOEPPER, J, HELBIG, W, NIEDERWIESER, D, LEIBLEIN, S, EDEL, E, LANGE, T, FIEDLER, F, FREUND, M, FRANKE, A, PASOLD, R

“…Mobilised peripheral blood stem cells are widely used for autografting in patients with chronic myeloid leukaemia (CML) and it is generally thought that a high…”
Get full text

An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia by Glasmacher, Axel, Cornely, Oliver, Ullmann, Andrew J., Wedding, Ulrich, Bodenstein, Heinrich, Wandt, Hannes, Boewer, Christian, Pasold, Rita, Wolf, Hans-Heinrich, Hänel, Mathias, Dölken, Gottfried, Junghanss, Christian, Andreesen, Reinhard, Bertz, Hartmut

“…Objectives: This trial studied the efficacy and safety of itraconazole and fluconazole in the prevention of invasive fungal infections in neutropenic patients…”
Get full text

Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma by Korfel, Agnieszka, Martus, Peter, Nowrousian, Mohammad R., Hossfeld, Dieter K., Kirchen, Heinz, Brücher, Joachim, Stelljes, Matthias, Birkmann, Josef, Peschel, Christian, Pasold, Rita, Fischer, Lars, Jahnke, Kristoph, Thiel, Eckhard

“…Summary The majority of the available data on primary central nervous system lymphoma (PCNSL) derive from small unicentric or oligocentric studies. In this…”
Get full text

Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma-a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO) by Koenigsmann, Michael, Knauf, Wolfgang U, Herold, Michael, Pasold, Rita, Müller, Gerd, Eschenburg, Henning, Kahl, Christoph, Lakner, Volker, Aßmann, Michael, Jentsch-Ullrich, Kathleen, Mohren, Martin, Bartsch, Rainer, Franke, Astrid

“…The therapy of patients with relapsed or refractory indolent lymphoma relies on the development of new drug combinations. The drugs bendamustine and…”
Get full text

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone OSHO : a randomized phase III study of the East German Study Group of Hematology and Oncology by PÖNISCH, W, MITROU, P. S, SUBERT, R, HARKSEL, B, GROBE, N, STELZER, E, SCHULZE, M, BITTRICH, A, FREUND, M, PASOLD, R, FRIEDRICH, Th, HELBIG, W, MERKLE, K, NIEDERWIESER, D, HEROLD, M, ASSMANN, M, WILHELM, G, DACHSELL, K, RICHTER, P, SCHIRMER, V, SCHULZE, A

Get full text

An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group by Höffken, G, Pasold, R, Pflüger, K H, Finke, J, Fauser, A A, Szelenyi, H, Wagner, J

“…To reduce drug acquisition costs, the clinical and bacteriological efficacy of low-dose ceftazidime i.v. (1 g tid) was compared with cefotaxime i.v. (2 g tid)…”
Get full text

Combined immunochemotherapy (R-FCM) is superior to chemo-therapy (FCM) alone in recurrent indolent lymphoma - results of a prospective randomized comparison by Hiddemann, W., Forstpointner, R., Fiedler, F., Gramatzki, M., Dörken, B., Illiger, H., Kneba, M., Pfreundschuh, M., Pasold, R., Parwaresch, R., Dreyling, M., Unterhalt, M.

Get full text

Intermediate-dose Cytarabine Treatment Delivered at Moderate Infusion Rates for De Novo Acute Myeloid Leukemia-Results of a phase I-II Study by Mantovani, Luisa, Hasenclever, Dirk, Krahl, Rainer, Pönisch, Wolfram, Herold, Michael, Pasold, Rita, Fiedler, Friedrich, Dölken, Gottfried, Kämpfe, Dietrich, Schmoll, Hans Joachim, Súbert, Rita, Kubel, Martin, Niederwieser, Dietger, Helbig, Werner

“…Published randomized trials on different cytarabine doses for the treatment of acute myeloid leukemia (AML) provide evidence of a dose-response effect…”
Get full text

Fludarabine Combination Therapy for the Treatment of Chronic Lymphocytic Leukemia by Schmitt, Barbara, Wendtner, Clemens M., Bergmann, Manuela, Busch, Raymonde, Franke, Astrid, Pasold, Rita, Schlag, Rudolf, Hopfinger, Georg, Hiddemann, Wolfgang, Emmerich, Bertold, Hallek, Michael

“…Fludarabine combination therapies have attained an increased popularity in the treatment of chronic lymphocytic leukemia (CLL). Among them, the combination of…”
Get full text

The distribution of mutans streptococci and lactobacilli depending on the caries prevalence in 11- to 12-year-old children by Kneist, S, Künzel, W, Pasold, R

“…20 Korean children, aged 11 to 12 years, participated in this study with the aim to compare the microbial composition of plaque samples in order to estimate,…”
Get more information